Thursday May 26th 2022

08:30-09:00Registration
09:00-09:15Welcome
09:15-10:15Board of Directors part 1 (by invitation only)
09:15-10:15Laboratory models of MH susceptibility (parallel session)
Kathryn Stowell, Christine Diggle & Vikas Kaura
10:15-11:00Coffee
11:00-12:45Scientific Session 1
11.00 Malignant hyperthermia in Poland - a survey study
Agnieszka Cieniewicz
11.15 Malignant Hyperthermia: characteristics of 182 suspected patients from a French diagnosis and follow-up center.
Beatrice Bruneau
11.30 description of the largest Slavonic group of patients investigated for risk of malignant hyperthermia. A retrospective observational national cohort study.
Martina Klincová
11.45 Malignant hyperthermia crisis: myth or reality?
A.F. Dalmas
12.00 Malignant hyperthermia outcomes following intravenous dantrolene treatment: a retrospective case report review and analysis
Robert Greenhalgh
12.15 Pitfalls of trigger-free anaesthesia – How safe is the wash out method?
Simon Zumsande
12.30 EMHG Working Group report:Training Curricula
12:45-13:45Lunch
13:45-15:30Scientific Session 2
13.45EMHG Working Group report: Webinars
14.00 Non-anaesthesic episodes of hyperthermia in a 4 yr old MHS patient
Henrik Rueffert
14.15 Muscle weakness, rhabdomyolysis and prolonged fatigue after SARS-CoV2 vaccination in a MHS patient
Boerge Bastian
14.30 Predictive factors in the in vitro muscle contracture test for the diagnosis of malignant hyperthermia in a Brazilian sample
Helga Cristina Almeida da Silva
14.45 Exclusion of familial variant- Does the potential risk for malignant hyperthermia justify invasive testing?
Benedikt Lother
15.15 Comparison of the Japanese calcium-induced calcium release test with the North American caffeine halothane contracture test for diagnosing malignant hyperthermia susceptibility.
Carlos Ibarra
15.15 EMHG Working Group report: eLearning
15:30-16:00Tea & Cakes
16:00-17:00Scientific Session 3
16.00 Transcriptomic changes associated with exertional heat illness.
Leon Chang
16.15 Guest Lecture: Malignant hyperthermia susceptibility and military service
Dr Paul Turnbull, Head of Survival and Thermal Medicine, Institute of Naval Medicine
17:15-18:30Walking tour
19:30-22:00Gala dinner